@prefix jvr: . @prefix mesh: . @prefix owl: . @prefix skos: . @prefix dc: . @prefix xsd: . jvr:-FS92QFB8-X mesh:allowableQualifier jvr:-H7K65Q8S-Z, jvr:-G4R176S9-J, jvr:-CJXMKG5Q-F, jvr:-NKM836P1-M, jvr:-Q3979798-W, jvr:-G30ZJ446-J, jvr:-S0CS1X5R-5, jvr:-R3QWLHRG-V, jvr:-Z9TSGBXH-4, jvr:-W6SQV79N-S, jvr:-HQRFT0C6-B, jvr:-CB30NGKB-3, jvr:-BT300B3G-Q, jvr:-XV06LPML-W, jvr:-TJHVZCRZ-0, jvr:-NFTHND7Q-8, jvr:-WZF2ZR3L-B, jvr:-NHL3D2X0-S, jvr:-R0ZCQ8X6-J, jvr:-T2TS0S41-N, jvr:-G7KXQWSR-5, jvr:-FWD2BGQ0-9, jvr:-THHNVC7V-3, jvr:-D0F21513-5, jvr:-WK5F724J-1, jvr:-T9HQD7ST-J, jvr:-SBNWSM1T-R, jvr:-L6C0XPHT-4, jvr:-NB0XHT3S-N ; owl:sameAs ; skos:inScheme jvr: ; skos:prefLabel "Héparine"@fr, "Heparin"@en ; a skos:Concept, mesh:Descriptor ; skos:narrower jvr:-TG30JT7C-9, jvr:-KL0V7W9W-3 ; dc:established "1960-01-01"^^xsd:date ; skos:hiddenLabel "Heparin Sodium"@en, "Sodium Heparin"@en, "Liquaemin"@en, "alpha-Heparin"@en ; skos:broader jvr:-VN5TFT27-J ; mesh:pharmacologicalAction jvr:-DG3TD8DB-1, jvr:-X0L5BV35-9 ; skos:altLabel "9005-49-6"@fr, "9005-49-6"@en, "Unfractionated Heparin"@en, "Heparinic Acid"@en ; skos:definition "A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts."@en ; dc:modified "2010-06-25"^^xsd:date ; dc:created "1999-01-01"^^xsd:date . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-KL0V7W9W-3 skos:prefLabel "Héparine bas poids moléculaire"@fr, "Heparin, Low-Molecular-Weight"@en ; a mesh:Descriptor, skos:Concept ; skos:broader jvr:-FS92QFB8-X . jvr:-DG3TD8DB-1 skos:prefLabel "Fibrinolytic Agents"@en, "Fibrinolytiques"@fr ; a mesh:Descriptor, skos:Concept . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G7KXQWSR-5 skos:prefLabel "biosynthèse (Qualificatif)"@fr, "biosynthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-Z9TSGBXH-4 skos:prefLabel "génétique (Qualificatif)"@fr, "genetics (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-VN5TFT27-J skos:prefLabel "Glycosaminoglycanes"@fr, "Glycosaminoglycans"@en ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-FS92QFB8-X . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-TG30JT7C-9 skos:prefLabel "Héparinoïde"@fr, "Heparinoids"@en ; a mesh:Descriptor, skos:Concept ; skos:broader jvr:-FS92QFB8-X . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T2TS0S41-N skos:prefLabel "ultrastructure (Qualifier)"@en, "ultrastructure (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CJXMKG5Q-F skos:prefLabel "deficiency (Qualifier)"@en, "déficit (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-X0L5BV35-9 skos:prefLabel "Anticoagulants"@en, "Anticoagulants"@fr ; a mesh:Descriptor, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WZF2ZR3L-B skos:prefLabel "physiology (Qualifier)"@en, "physiologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept .